GlassScriptPhysician profile
Patricia Graffice
NPI 1427286327
$3,782.66
in general payments reported to CMS, 2019-2025
31 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $751 · 2022: $756 · 2023: $1,106 · 2024: $639 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,275.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $573.41 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $487.43 | 2021-2025 | Wainua, Brilinta, Lokelma |
| Janssen Pharmaceuticals, INC | $393.92 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $346.68 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $266.97 | 2021-2025 | Verquvo |
| Amgen INC. | $223.54 | 2022-2025 | Repatha, Repatha |
| Medtronic, INC. | $140.88 | 2022-2024 | Corevalve Evolut R |
| Scpharmaceuticals INC. | $119.85 | 2023-2025 | |
| Corcept Therapeutics | $116.90 | 2023 | Korlym |
| Lexicon Pharmaceuticals, INC. | $113.55 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $108.01 | 2023-2024 | Camzyos, Eliquis |
| Boston Scientific Corporation | $105.29 | 2023 | Watchman, Watchman Access System, Watchman Flx |
| Pfizer INC. | $97.91 | 2021-2025 | |
| Axsome Therapeutics, INC. | $87.20 | 2024 | Sunosi |
| Novo Nordisk INC | $77.38 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.07 | 2024-2025 | Lifevest |
| Heartflow, INC. | $59.10 | 2024 | |
| Amarin Pharma, INC. | $57.63 | 2021-2022 | |
| Philips North America LLC | $48.75 | 2022-2025 | Extended Holter |
| Kestra Medical Technology Services, INC. | $43.60 | 2023 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $38.53 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $28.50 | 2023 | Livalo |
| Abbott Laboratories | $23.84 | 2025 | Confirm Rx |
| Edwards Lifesciences Corporation | $21.59 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $20.66 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $19.91 | 2021 | |
| Astellas Pharma US INC | $19.60 | 2021 | |
| Inspire Medical Systems, INC. | $18.79 | 2023 | Inspire |
| Cmp Pharma, INC. | $18.15 | 2023 | Carospir, Tadliq, Norliqva |
| Sanofi-Aventis U.S. LLC | $16.41 | 2021 | |
| Lantheus Medical Imaging, INC. | $12.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Graffice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.